Fatty acid metabolism is highly associated with pancreatic cancer tumorigenesis and some studies reported that LXRs inhibit the transcriptional targets FASN, and SREBP1C that are involved in fatty acid metabolism thereby inhibiting cancer growth (Joseph et al., 2002). The gene discussed is SREBF1; the disease is familial pancreatic carcinoma.